Diallyl Disulfide (DADS), a Constituent of Garlic, Inactivates NF-κB and Prevents Colitis-Induced Colorectal Cancer

Shakir M Saud1, Weidong Li2, Zane Gray3

  • 1Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, Rockville, Maryland. Laboratory of Cancer Prevention, Center for Cancer Research, National Cancer Institute, Frederick, Maryland.

Insights

Diallyl disulfide (DADS) from garlic suppressed colorectal cancer in mice by reducing inflammation. DADS works by inhibiting GSK-3β, which lowers NF-κB activity, preventing tumor growth.

Area of Science:

  • Oncology
  • Gastroenterology
  • Molecular Biology

Background:

  • Garlic is believed to possess medicinal properties, potentially reducing cancer risk.
  • Sulfur-containing compounds in garlic, such as diallyl disulfide (DADS), are thought to contribute to its chemopreventive effects via anti-inflammatory actions.

Purpose of the Study:

  • To investigate the chemopreventive effects of DADS on colorectal tumorigenesis in a mouse model.
  • To elucidate the molecular mechanisms underlying DADS's anti-cancer activity, focusing on inflammatory pathways.

Main Methods:

  • FVB/N mice were treated with azoxymethane (AOM) and dextran sodium sulfate (DSS) to induce colorectal cancer.
  • Mice received a diet supplemented with 85 ppm DADS.
  • In vitro studies used SW480 colorectal cancer cells to examine DADS's effects on NF-κB and GSK-3β signaling.

Main Results:

  • DADS supplementation significantly reduced tumor incidence, number, and burden in AOM/DSS-treated mice.
  • Mice on the DADS-supplemented diet showed faster resolution of DSS-induced inflammation.
  • In vitro and in vivo studies confirmed that DADS suppresses NF-κB signaling by inhibiting GSK-3β.

Conclusions:

  • Diallyl disulfide (DADS) demonstrates chemopreventive efficacy against colorectal cancer in a mouse model.
  • DADS exerts its effects by suppressing inflammation through the inhibition of GSK-3β and subsequent reduction of NF-κB nuclear localization.
  • These findings highlight DADS as a potential therapeutic agent for colorectal cancer prevention.

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
602
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
722
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
606
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.0K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
655